Related Experiment Video
Updated: Jun 13, 2026
07:34
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
1Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Human Pathology
|May 15, 2010
Summary
Multifocal prostate cancer presents challenges in staging and treatment. This review explores multifocal prostatic adenocarcinoma
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Prostatic adenocarcinoma is the most common cancer in men, frequently presenting as multifocal disease.
- Current tumor classification and grading systems face ongoing debate regarding optimal curative treatment.
Purpose of the Study:
- To review recent advancements in the pathogenesis of multifocal prostatic adenocarcinoma.
- To discuss the biologic, pathologic, prognostic, and therapeutic implications of multifocality.
Main Methods:
- Literature review of recent progress in understanding multifocal prostatic adenocarcinoma.
- Analysis of existing tumor classification and staging systems, including the 2010 revision.
- Examination of the impact of multifocality and clonal heterogeneity on treatment efficacy.
Main Results:
- Multifocality complicates accurate clinical staging, necessitating revisions in classification systems.
- The clinical significance of T2 substaging in the 2010 revision remains questionable.
- Tumor multifocality and heterogeneity may affect the efficacy of focal ablative therapies.
Conclusions:
- Accurate staging and grading of multifocal prostate cancer require further refinement.
- The clinical significance of secondary tumors and chromosomal abnormalities in metastasis needs continued investigation.
- Understanding multifocality is crucial for optimizing treatment strategies for prostatic adenocarcinoma.
